» Articles » PMID: 31889098

Enhancement of Immune Response Against Bordetella Spp. by Disrupting Immunomodulation

Overview
Journal Sci Rep
Specialty Science
Date 2020 Jan 1
PMID 31889098
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Well-adapted pathogens must evade clearance by the host immune system and the study of how they do this has revealed myriad complex strategies and mechanisms. Classical bordetellae are very closely related subspecies that are known to modulate adaptive immunity in a variety of ways, permitting them to either persist for life or repeatedly infect the same host. Exploring the hypothesis that exposure to immune cells would cause bordetellae to induce expression of important immunomodulatory mechanisms, we identified a putative regulator of an immunomodulatory pathway. The deletion of btrS in B. bronchiseptica did not affect colonization or initial growth in the respiratory tract of mice, its natural host, but did increase activation of the inflammasome pathway, and recruitment of inflammatory cells. The mutant lacking btrS recruited many more B and T cells into the lungs, where they rapidly formed highly organized and distinctive Bronchial Associated Lymphoid Tissue (BALT) not induced by any wild type Bordetella species, and a much more rapid and strong antibody response than observed with any of these species. Immunity induced by the mutant was measurably more robust in all respiratory organs, providing completely sterilizing immunity that protected against challenge infections for many months. Moreover, the mutant induced sterilizing immunity against infection with other classical bordetellae, including B. pertussis and B. parapertussis, something the current vaccines do not provide. These findings reveal profound immunomodulation by bordetellae and demonstrate that by disrupting it much more robust protective immunity can be generated, providing a pathway to greatly improve vaccines and preventive treatments against these important pathogens.

Citing Articles

Eosinophils as drivers of bacterial immunomodulation and persistence.

Parrish K, Gestal M Infect Immun. 2024; 92(9):e0017524.

PMID: 39007622 PMC: 11385729. DOI: 10.1128/iai.00175-24.


Copper management strategies in obligate bacterial symbionts: balancing cost and benefit.

Rivera-Millot A, Harrison L, Veyrier F Emerg Top Life Sci. 2023; 8(1):29-35.

PMID: 38095549 PMC: 10903467. DOI: 10.1042/ETLS20230113.


Bordetella spp. block eosinophil recruitment to suppress the generation of early mucosal protection.

First N, Parrish K, Martinez-Perez A, Gonzalez-Fernandez A, Bharrhan S, Woolard M Cell Rep. 2023; 42(11):113294.

PMID: 37883230 PMC: 11682855. DOI: 10.1016/j.celrep.2023.113294.


T3SS chaperone of the CesT family is required for secretion of the anti-sigma factor BtrA in .

Drzmisek J, Petrackova D, Dienstbier A, curnova I, Vecerek B Emerg Microbes Infect. 2023; 12(2):2272638.

PMID: 37850324 PMC: 10732220. DOI: 10.1080/22221751.2023.2272638.


and : Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations.

Miguelena Chamorro B, De Luca K, Swaminathan G, Longet S, Mundt E, Paul S Clin Microbiol Rev. 2023; 36(3):e0016422.

PMID: 37306571 PMC: 10512794. DOI: 10.1128/cmr.00164-22.


References
1.
Mann P, Elder K, Kennett M, Harvill E . Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. Infect Immun. 2004; 72(11):6650-8. PMC: 523027. DOI: 10.1128/IAI.72.11.6650-6658.2004. View

2.
Yuk M, Harvill E, Miller J . The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol Microbiol. 1998; 28(5):945-59. DOI: 10.1046/j.1365-2958.1998.00850.x. View

3.
Pacheco A, Sperandio V . Inter-kingdom signaling: chemical language between bacteria and host. Curr Opin Microbiol. 2009; 12(2):192-8. PMC: 4852728. DOI: 10.1016/j.mib.2009.01.006. View

4.
Smallridge W, Rolin O, Jacobs N, Harvill E . Different effects of whole-cell and acellular vaccines on Bordetella transmission. J Infect Dis. 2014; 209(12):1981-8. PMC: 4038146. DOI: 10.1093/infdis/jiu030. View

5.
Pilione M, Pishko E, Preston A, Maskell D, Harvill E . pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infect Immun. 2004; 72(5):2837-42. PMC: 387902. DOI: 10.1128/IAI.72.5.2837-2842.2004. View